These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8194586)

  • 1. Priming effect of vasoactive intestinal peptide on the respiratory burst of neutrophils non-mediated by plasma membrane receptors.
    López-González MA; Lucas M
    Experientia; 1994 May; 50(5):486-8. PubMed ID: 8194586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-independent mechanisms are involved in the priming of neutrophil's oxidase by vasoactive intestinal peptide.
    Pedrera C; Lucas M; Bellido L; López-González MA
    Regul Pept; 1994 Dec; 54(2-3):505-11. PubMed ID: 7716283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide enhances phorbol myristate acetate-induced chemiluminescence in human lymphocytes.
    Lopez-Gonzalez MA; Guerrero JM; Lucas M
    Life Sci; 1992; 51(23):1803-10. PubMed ID: 1331643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trophoblast cells inhibit neutrophil extracellular trap formation and enhance apoptosis through vasoactive intestinal peptide-mediated pathways.
    Calo G; Sabbione F; Vota D; Paparini D; Ramhorst R; Trevani A; Pérez Leirós C
    Hum Reprod; 2017 Jan; 32(1):55-64. PubMed ID: 27932441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide inhibits fMLP-induced respiratory burst in human lymphocytes.
    Bellido L; López-González MA; Pedrera C; Lucas M
    Life Sci; 1994; 54(24):1909-16. PubMed ID: 8196509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors.
    Virgolini I; Yang Q; Li S; Angelberger P; Neuhold N; Niederle B; Scheithauer W; Valent P
    Cancer Res; 1994 Feb; 54(3):690-700. PubMed ID: 7905785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-promoting phorbol esters interfere with the vasoactive intestinal peptide receptor/effector system in rat prostatic epithelial cells.
    Escudero F; Carmena MJ; Prieto JC
    Biochem Biophys Res Commun; 1987 Nov; 149(1):221-6. PubMed ID: 2825698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal peptide modulation of adherence and mobility in rat peritoneal lymphocytes and macrophages.
    de la Fuente M; Delgado M; del Rio M; Garrido E; Leceta J; Hernanz A; Gomariz RP
    Peptides; 1994; 15(7):1157-63. PubMed ID: 7854966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-8 priming of human neutrophils is not associated with persistently altered calcium fluxes but is additive with lipopolysaccharide.
    Van Dervort AL; Lam C; Culpepper S; Tuschil AF; Wesley RA; Danner RL
    J Leukoc Biol; 1998 Oct; 64(4):511-8. PubMed ID: 9766632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.
    Summers MA; O'Dorisio MS; Cox MO; Lara-Marquez M; Goetzl EJ
    J Pharmacol Exp Ther; 2003 Aug; 306(2):638-45. PubMed ID: 12750439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of inflammation by vasoactive intestinal peptide and bombesin: lack of effects on neutrophil apoptosis.
    Djanani AM; Kähler ChM
    Acta Med Austriaca; 2002; 29(3):93-6. PubMed ID: 12168570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phorbol ester-induced priming of superoxide generation by phosphatidic acid-stimulated neutrophils and granule-free neutrophil cytoplasts.
    Siddiqui RA; English D; Harvey K; Cui Y; Martin MI; Wentland J; Akard L; Jansen J; Thompson J; Garcia JG
    J Leukoc Biol; 1995 Aug; 58(2):189-95. PubMed ID: 7643013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive intestinal peptide receptor/adenylate cyclase system: differences between agonist- and protein kinase C-mediated desensitization and further evidence for receptor internalization.
    Turner JT; Bollinger DW; Toews ML
    J Pharmacol Exp Ther; 1988 Nov; 247(2):417-23. PubMed ID: 2846820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VIP1 and VIP2 receptors but not PVR1 mediate the effect of VIP/PACAP on cytokine production in T lymphocytes.
    Jiang X; Wang HY; Yu J; Ganea D
    Ann N Y Acad Sci; 1998 Dec; 865():397-407. PubMed ID: 9928038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Volume-dependent regulation of the respiratory burst of activated human neutrophils.
    Kuchkina NV; Orlov SN; Pokudin NI; Chuchalin AG
    Experientia; 1993 Nov; 49(11):995-7. PubMed ID: 8253173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide stimulation of human renal adenylate cyclase in vitro.
    Charlton BG; Neal DE; Simmons NL
    J Physiol; 1990 Apr; 423():475-84. PubMed ID: 2167366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
    Mittag TW; Tormay A; Podos SM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct evidence for functional coupling of the vasoactive intestinal peptide receptor to Gi3 in native lung membranes.
    Diehl NL; Kermode JC; Shreeve SM
    Mol Pharmacol; 1996 Sep; 50(3):624-30. PubMed ID: 8794903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide specificity for stimulation of corticotropin secretion: activation of overlapping pathways by the vasoactive intestinal peptide family and corticotropin-releasing factor.
    Westendorf JM; Schonbrunn A
    Endocrinology; 1985 Jun; 116(6):2528-35. PubMed ID: 2859986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.